Equities

Nyxoah SA

Nyxoah SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)8.76
  • Today's Change-0.04 / -0.45%
  • Shares traded12.19k
  • 1 Year change+59.85%
  • Beta0.5144
Data delayed at least 15 minutes, as of Nov 08 2024 16:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5895136
Total Receivables, Net5.973.242.51
Total Inventory3.320.880.35
Prepaid expenses----1.69
Other current assets, total1.321.28--
Total current assets68100140
Property, plant & equipment, net7.985.625.24
Goodwill, net------
Intangibles, net474025
Long term investments------
Note receivable - long term1.170.170.16
Other long term assets------
Total assets124146171
LIABILITIES
Accounts payable4.101.872.39
Accrued expenses4.805.032.85
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.221.111.14
Other current liabilities, total4.336.915.19
Total current liabilities141512
Total long term debt111111
Total debt131212
Deferred income tax0.01--0.01
Minority interest------
Other liabilities, total0.190.060.09
Total liabilities262622
SHAREHOLDERS EQUITY
Common stock4.934.444.43
Additional paid-in capital246228228
Retained earnings (accumulated deficit)(153)(113)(84)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.140.180.20
Total equity98120149
Total liabilities & shareholders' equity124146171
Total common shares outstanding292626
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.